69 results
8-K
PCSA
Processa Pharmaceuticals Inc
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
to Lincoln Park as a commitment fee in connection with entering into the Purchase Agreement (the “Commitment Shares” and together with the Purchase Shares … the issuance of the Commitment Shares to Lincoln Park under the Purchase Agreement, such that the transactions contemplated by the Purchase Agreement
424B5
PCSA
Processa Pharmaceuticals Inc
24 Mar 22
Prospectus supplement for primary offering
4:15pm
issued to Lincoln Park as commitment shares under the Purchase Agreement. This prospectus also covers the resale of these shares by Lincoln Park … stock issued to Lincoln Park as consideration for its commitment to purchase shares of our common stock under the Purchase Agreement
10-Q/A
2013 Q2
PCSA
Processa Pharmaceuticals Inc
6 Sep 13
Quarterly report (amended)
12:00am
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
the U.S. Securities and Exchange Commission.
(ss) “Securities” means, collectively, the Purchase Shares and the Commitment Shares.
(tt) “Securities Act … of the Commitment Shares (as defined below in Section 5(e)) and the reservation for issuance and the issuance of the Purchase Shares issuable under
10-Q/A
trtpc2dc71nm61 6s
6 Sep 13
Quarterly report (amended)
12:00am
10-Q/A
kh3ccw 2068b
6 Sep 13
Quarterly report (amended)
12:00am
8-K
EX-10.2
swu246lqbp6 llg
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
10-Q/A
n4iwj3
6 Sep 13
Quarterly report (amended)
12:00am
424B3
yv598sonsiz4
13 Nov 18
Prospectus supplement
9:39pm
8-K
EX-5.1
obs4k lcs
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
ugt07xyhb
30 Mar 18
License for the Clinical Stage Compound CTP-499 and Plans to Develop
12:00am
8-K
EX-99.1
doku 49ii1
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
syuoxzzjagfqmt21f4p
3 Oct 19
Entry into a Material Definitive Agreement
12:00am
10-Q
0jl2rf 01y
8 Aug 13
Quarterly report
12:00am